The Transportation Security Administration (TSA) has officially updated its operational guidance to permit passengers to carry medical cannabis on flights. This policy shift follows the federal government's ongoing efforts to reclassify medical cannabis from Schedule I to Schedule III under the Controlled Substances Act. According to the agency’s updated website, which reflects changes made on April 27, TSA screening procedures remain primarily focused on security threats such as weapons, explosives, and prohibited items, rather than the search for illicit substances.
While the TSA clarified that its officers are not looking for marijuana, the agency noted that if a controlled substance is discovered during routine security screening, officers are required to refer the matter to local law enforcement. This regulatory adjustment represents a significant milestone in the normalization of cannabis commerce and movement within the United States. For industry stakeholders, this change reduces the friction associated with cannabis-related travel, potentially influencing regional market dynamics and consumer behavior.
However, operators should remain cognizant that local and state laws still apply, and the transition remains subject to the final implementation details of the federal reclassification process. As the legal landscape continues to evolve toward Schedule III status, the aviation industry’s stance aligns with broader shifts in federal enforcement priorities, signaling a reduced risk profile for travelers carrying medical cannabis products.